Table 1.

Clinical scope of onconephrology

AKI in patients with cancer

CKD in patients with cancer

BP disorder from chemotherapy

Electrolyte disorders of malignancy

Tumor lysis syndrome

Multiple myeloma–related kidney disease

Secondary glomerular diseases from malignancy or related to cancer treatment

Stem cell transplant–related kidney diseases

CAR-T-cell therapy–related kidney disorders

Chemotherapy dosing adjustments to kidney disease

Kidney disease after nephrectomy

Paraproteinemias

Anticancer drug–related nephropathies

CAR, chimeric antigen receptor.